RedMane Appoints Marc Campbell as Chief Operating Officer
CHICAGO, Oct. 28, 2024 /PRNewswire/ -- As a leader in the Health and Human Services (HHS) information systems market, Chicago-based...
Month: October 2024
KRELL TECHNOLOGIES LAUNCHES PHOTONICS OUTREACH PROGRAM FOR HIGH SCHOOLS
Students from Pleasantville High School Delve into the World of Photonics NEPTUNE CITY, N.J., Oct. 28, 2024 /PRNewswire/ -- Krell...
Danforth Technology Company launches new startup
ST. LOUIS, Oct. 28, 2024 /PRNewswire/ -- The Danforth Technology Company (DTC) today announced the launch of Metablify, a startup that...
Ocutrx Unveils DigiLoupes™ Headset with Advanced AR, XR, and Pancake Lens Technology for Medical and Surgical Applications
New Headset Model to Display at AWE EU October 29-30 in Vienna COLORADO SPRINGS, Colo. and VIENNA, Austria, Oct. 28, 2024 /PRNewswire/...
3 Trends I’m Watching in Sustainability
Amalia Adler-Waxman, SVP, Head of Sustainability at TevaNORTHAMPTON, MA / ACCESSWIRE / October 28, 2024 / Teva Pharmaceutical My name...
Cantargia Reports New Results from Clinical Studies Investigating Nadunolimab in Several Forms of Cancer; Supporting Ongoing Strategies
LUND, SE / ACCESSWIRE / October 28, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB); (Nasdaq Stockholm:CANTA) today announced new clinical...
Pharmacy Healthy and Information Technology (PHIT) Collaborative Announces New Executive Director Jeff Rochon
ALEXANDRIA, VA / ACCESSWIRE / October 28, 2024 / The Executive Committee of the Pharmacy Health and Information Technology (PHIT)...
CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings
Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the...
MentalHealth.com Launches Mental Health Network
SAN FRANCISCO, CA / ACCESSWIRE / October 28, 2024 / Leading health technology company MentalHealth.com is proud to announce the...
CureVac to Present at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / October 28, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company...
Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets
Strengthens AI Nose Gas Sensing Technology with Additional Exclusively Licensed PatentsSecures Exclusive Rights to Breakthrough Nitrogen-Oxygen Separation Technology with Superior...
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
LOS GATOS, CA / ACCESSWIRE / October 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company...
MIRA Pharmaceuticals’ Ketamir-2 Shows 60% Greater Efficacy Than FDA-Approved Gabapentin in Reversing Chemotherapy-Induced Neuropathic Pain
Promising Preclinical Results Position Ketamir-2 as a Potential Breakthrough Therapy That Surpasses Current Treatments, With Results to Be Presented at...
IRLAB: Invitation to the Interim Report for Q3 2024 Presentation and Webcast
GOTHENBURG, SWEDEN / ACCESSWIRE / October 28, 2024 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing...
NLS Pharmaceutics Ltd. Regains Full Compliance with Nasdaq Listing Requirements
ZURICH, SWITZERLAND / ACCESSWIRE / October 28, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
MARLBOROUGH, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...
Immunophotonics to Present at the 2024 ThinkEquity Conference
ST. LOUIS, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Immunophotonics, Inc. a clinical-stage biotech company focused on the discovery and development...
Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease
New Data Confirms DIFS Improves Cognitive Function and Restores Brain Activity in Alzheimer's Patients HOUSTON, TX, Oct. 28, 2024 (GLOBE...
TOMI Environmental Solutions Announces Preliminary Financial Results for Third Quarter 2024 With Continued Profitability and Global Market Expansion
FREDERICK, Md., Oct. 28, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI” or the “Company”) (NASDAQ: TOMZ), a global...
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement with the University of Cincinnati to Study Certepetide for the Treatment of Endometriosis
Strategic partnership explores therapeutic effect of Lisata’s novel cyclic peptide product candidate, certepetide, in combination with bevacizumabBASKING RIDGE, N.J., Oct....